Can-Fite BioPharma Ltd.
CANFAMEXHealthcare● Active
$3.08
+$0.00(+0.00%)
Market Cap$1657040
P/E Ratio—
52W High$23.4
52W Low$2.83
Can-Fite BioPharma Ltd.（CANF）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CANF · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $8.54M | $7.89M | $8.92M | $7.98M | $19.14M |
| Net Receivables | $0.07M | $0.00M | $0.00M | $0.05M | $0.05M |
| Inventory | $0.00M | $0.00M | $0.00M | ($0.04M) | ($0.05M) |
| Total Current Assets | $9.44M | $8.98M | $9.91M | $9.16M | $20.07M |
| PP&E Net | $0.07M | $0.14M | $0.08M | $0.13M | $0.18M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $9.51M | $9.12M | $9.99M | $9.28M | $20.25M |
| Liabilities | |||||
| Short-Term Debt | $0.06M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $1.16M | $0.62M | $0.43M | $0.90M | $0.95M |
| Total Current Liabilities | $2.73M | $2.05M | $2.02M | $2.50M | $2.73M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $3.92M | $3.68M | $3.75M | $4.81M | $5.87M |
| Stockholders Equity | |||||
| Retained Earnings | ($176.19M) | ($166.36M) | ($158.48M) | ($150.85M) | ($140.67M) |
| Total Stockholders Equity | $5.59M | $5.44M | $6.24M | $4.47M | $14.38M |
| Total Liab & Equity(computed) | $9.51M | $9.12M | $9.99M | $9.28M | $20.25M |
| Debt Summary | |||||
| Total Debt | $0.07M | $0.10M | $0.04M | $0.06M | $0.12M |
| Net Debt | ($5.46M) | ($4.72M) | ($4.24M) | ($2.92M) | ($4.27M) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Can-Fite BioPharma Ltd.
关于Can-Fite BioPharma Ltd.（CANF）资产负债表
Can-Fite BioPharma Ltd.总资产$0.01B，现金及短期投资$0.01B，总负债$0.00B，总债务$0.00B，股东权益$0.01B。
常见问题
CANF · 4 问Can-Fite BioPharma Ltd.总债务$0.00B，净债务($0.01B)。
CANF total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10